mestag therapeutics

Advertisement

cGxPJobs Banner

Mestag Therapeutics Doses First Patient in STARLYS Trial of MST-0312 for Solid Tumors

CAMBRIDGE, UK, May 19, 2026 Mestag Therapeutics announced the first patient has been dosed in the Phase 1 STARLYS...

By cGxPwire Editor
May 20, 2026

Read More

Mestag Therapeutics Secures $40M for Clinical Trial

CAMBRIDGE, UK, March 17, 2026 Mestag Therapeutics has announced a $40 million financing round to advance its first-in-class oncology...

By cGxPwire Editor
March 18, 2026

Read More

Advertisement

cGxPJobs

Directory